Vijaya Diagnostic Centre Limited concluded the fiscal year 2026 with robust financial results, reporting consolidated revenues of INR 814 crores, representing a 19.5% year-on-year growth. The fourth quarter was particularly strong, with revenue rising 26.6% and an EBITDA margin of 43.5%. The company continues to focus on volume-led growth, network expansion into new geographies, and significant investments in advanced diagnostic technology, including plans for automated laboratory systems and genomic testing.
Fiscal Year 2026 Financial Highlights
Vijaya Diagnostic Centre Limited marked a landmark year in FY26, with revenues crossing the INR 800 crore milestone. The consolidated revenue for the year stood at INR 814 crores compared to INR 681 crores in the previous year. Profit after tax reached INR 173 crores with a healthy margin of 21.2%. The fourth quarter was a highlight for the company, delivering a revenue growth of 26.6% year-on-year, supported by a 18.5% increase in test volumes.
Strategic Growth and Operational Expansion
Over the last five years since listing, the company has successfully doubled its network from 81 to 162 centers and expanded its footprint from two states to six. Management remains committed to a B2C-focused, integrated business model, which currently accounts for 92% of total revenue. Future expansion plans for FY27 include the commissioning of 4 to 5 hubs and 10 to 12 spokes, alongside the launch of a state-of-the-art, fully automated laboratory in Panjagutta, Hyderabad to improve operational productivity.
Investing in Technology and Specialized Services
To sustain its competitive edge, the company is significantly ramping up investments in technology, including AI-based radiology solutions for modalities such as CT KUB and dental scans, and the introduction of Genomic Testing as part of its specialized diagnostic offerings. These initiatives are designed to improve customer experience and enhance the company’s ability to offer advanced medical insights across its network.
Geographic Performance and Future Outlook
The company continues to see strong performance in its core market of Hyderabad, which contributed 67% to quarterly revenue. Meanwhile, newer geographies like Pune have shown significant recovery and growth, with 16% year-on-year growth reported for the quarter. Looking ahead, management maintains a disciplined approach to capital expenditure—estimated between INR 140 crores and INR 150 crores for FY27—with a continued focus on profitable, volume-driven growth across all its clusters.
Source: BSE
